Table 1.
Features | Total
|
miR-18a expression
|
P-value | |
---|---|---|---|---|
N=123 | High | Low | ||
| ||||
Gender | 0.835 | |||
Male | 97 | 47 | 50 | |
Female | 26 | 12 | 14 | |
Age, year | 0.945 | |||
≤50 | 33 | 16 | 17 | |
>50 | 90 | 43 | 47 | |
AFP | 0.023* | |||
<400 ng/mL | 30 | 9 | 21 | |
≥400 ng/mL | 93 | 50 | 43 | |
TNM stage | <0.001 | |||
I–II | 62 | 7 | 55 | |
III–IV | 61 | 52 | 9 | |
Tumor size | <0.001 | |||
≤5 cm | 53 | 6 | 47 | |
>5 cm | 70 | 53 | 17 | |
Intrahepatic vascular invasion | <0.001 | |||
Yes | 64 | 45 | 19 | |
No | 59 | 14 | 45 |
Note:
P<0.05.
Abbreviations: AFP, alpha-fetoprotein; HCC, hepatocellular carcinoma; miR-18a, microRNA-18a.